摘要
目的探讨微钛钉种植体治疗上颌前突的临床效果。方法分析武汉大学人民医院口腔科2016年2月～2017年2月收治的100例上颌前突患者的临床资料,依据治疗方式不同分为对照组和观察组,每组50例。对照组采用传统支抗治疗,观察组采用微钛钉种植体治疗。观察两组上颌前突患者治疗前后X线头影测量值,比较两组上颌前突患者临床疗效和并发症发生率。结果两组上颌前突患者治疗前U1-Y、SNB、U6-Y、U1-SN、ANB、U1-L1比较,差异均无统计学意义(P> 0.05)。治疗后两组患者U1-Y、U1-SN、ANB均低于同组治疗前,U1-L1均高于同组治疗前,观察组患者治疗后U1-Y、U1-SN、ANB均低于对照组,U1-L1高于对照组(P <0.05)。观察组患者临床治疗总有效率高于对照组,并发症发生率低于对照组(P <0.05)。结论微钛钉种植体治疗上颌前突患者,临床表现改善良好,效果明显,并发症少,值得临床推广应用。
Objective To explore clinical efficacy of treating maxillary protrusion deformity by titanium microscrew implant.Methods Clinical data of 100 cases with maxillary protrusion deformity in Department of Stomatology,Renmin Hospital of Wuhan University from February 2016 to February 2017 was analyzed.All the cases were divided into control group and observation group by different treating methods with 50 cases in each group.The control group was treated by conventional anchorage method and the observational group was treated by titanium microscrew implant.The X-ray head shadow measurement difference after treatment were observed.Clinical efficacy and adverse reaction rate of the patients with maxillary protrusion deformity were compared.Results Before treatment,the U1-Y,SNB,U6-Y,U1-SN,ANB,U1-L1 of the two groups had no significant difference(P﹥0.05).After treatment,U1-Y,U1-SN,ANB of the two groups were lower than those before treatment,U1-L1 of the two groups was higher than that before treatment.U1-Y,U1-SN,ANB in the observation group were lower than those in the control group and U1-L1 was higher than that in the control group(P﹤0.05).The total effective rate in the observation group was higher than that in the control group,and the adverse reaction rate was lower than that in the control group(P﹤0.05).Conclusion The maxillary protrusion deformity patients treating by titanium microscrew implant has good improvement in clinical manifestation,and the efficacy is significant with few complications,which is worth clinical promotion.
作者
张洪涛
雷志敏
ZHANG Hongtao;LEI Zhimin(Department of Stomatology,Renmin Hospital of Wuhan University,Hubei Province,Wuhan 430060,China)
出处
《中国医药导报》
CAS
2019年第2期106-108,112,共4页
China Medical Herald
基金
湖北省荆门市科技计划项目(荆科计[2014]7号)
